The DORA trial: A non-comparator randomised phase II multi-center maintenance study of olaparib alone or olaparib in combination with durvalumab in platinum treated advanced triple negative breast cancer (TNBC) Meeting Abstract


Authors: Dent, R.; Tan, T.; Kim, S. B.; Traina, T.; McArthur, H.; Im, Y. H.; Creel, T.; Blackwell, K.
Abstract Title: The DORA trial: A non-comparator randomised phase II multi-center maintenance study of olaparib alone or olaparib in combination with durvalumab in platinum treated advanced triple negative breast cancer (TNBC)
Meeting Title: 40th Annual San Antonio Breast Cancer Symposium (SABCS 2017)
Journal Title: Cancer Research
Volume: 78
Issue: 4 Suppl.
Meeting Dates: 2017 Dec 5-9
Meeting Location: San Antonio, TX
ISSN: 0008-5472
Publisher: American Association for Cancer Research  
Date Published: 2018-02-01
Language: English
ACCESSION: WOS:000425489400106
PROVIDER: wos
DOI: 10.1158/1538-7445.SABCS17-OT3-04-02
Notes: Meeting Abstract: OT3-04-02 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Tiffany A Traina
    250 Traina